Glutamate and tumor-associated epilepsy

Oncotarget

Volumn 2, Issue 11, 2011, Pages 823-824

  Sontheimer, Harald ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID;

ANIMAL; BRAIN TUMOR; EDITORIAL; EPILEPSY; HUMAN; METABOLISM;

ANIMALS; BRAIN NEOPLASMS; EPILEPSY; GLUTAMIC ACID; HUMANS;

EID: 84858843350     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.350     Document Type: Note

References (10)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34(3):453-468.
2. van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ. Efficacy of antiepileptic drugs in patients with gliomas and seizures. J Neurol 2009; 256(9):1519-1526.
3. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat Med 2001; 7(9):1010-1015.
4. Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999; 59(17):4383-4391.
5. Savaskan NE, Heckel A, Hahnen E, Engelhorn T, Doerfler A, Ganslandt O et al. Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med 2008; 14(6):629-632.
6. Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol 2001; 58(3):365-370.
7. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 2005; 25(31):7101-7110.
8. Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T et al. Glutamate release by primary brain tumors induces epileptic activity. Nat Med 2011.
9. Marcus HJ, Carpenter KL, Price SJ, Hutchinson PJ. In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J Neurooncol 2010; 97(1):11-23.
10. Lo M, Wang YZ, Gout PW. The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 2008; 215(3):593-602.